Literature DB >> 2676403

Penetration of third-generation cephalosporins into human peritoneal tissue.

S A Berger1, M Dan, F Serour, A Gorea, A Levenberg, M Krispin.   

Abstract

Each of 40 patients underwent elective laparotomy following administration of a single 1.0-gram intravenous dose of ceftizoxime, ceftriaxone, cefoperazone or cefotaxime. Therapeutic concentrations of cefoperazone and ceftriaxone were achieved in peritoneal tissue in 20/20 patients. Only 9/20 samples from patients receiving the other two antibiotics had detectable antibiotic activity. The antibiotic concentration in peritoneal fluid (7 samples) was 2.36-11.15 times higher than that of concurrently obtained peritoneal tissue. When adjusted for the in vitro susceptibility (MIC) of potential peritoneal pathogens, our data suggest that ceftriaxone and cefoperazone may be preferable to other third-generation cephalosporins for the prophylaxis and therapy of intraabdominal infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676403     DOI: 10.1159/000238689

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  5 in total

Review 1.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

3.  Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.

Authors:  J Gómez-Jiménez; E Ribera; I Gasser; M A Artaza; O Del Valle; A Pahissa; J M Martínez-Vázquez
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

4.  Concentrations in plasma and tissue penetration of ceftriaxone and ornidazole during liver transplantation.

Authors:  A Steib; B Jacoberger; M Von Bandel; F Beck; J P Beller; K Boudjema; J C Koffel; J C Otteni
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 5.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.